slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
27,35 TWD | +0,74% | +0,74% | -8,53% |
Vakgebied
Aantal werknemers: 82
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drugs for Obstructive Airway Diseases
100,0
%
| 24 | 100,0 % | 26 | 100,0 % | +9,30% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
84,5
%
| 11 | 44,9 % | 22 | 84,5 % | +105,91% |
Hong Kong
6,8
%
| 1 | 3,9 % | 2 | 6,8 % | +89,99% |
Other
4,4
%
| - | - | 1 | 4,4 % | - |
China
4,3
%
| 9 | 39,4 % | 1 | 4,3 % | -87,99% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Hsiu Wu
CEO | Chief Executive Officer | - | 01-11-11 |
Chien Yao Yang
DFI | Director of Finance/CFO | - | 23-07-13 |
Chih Hui Lin
CHM | Chairman | - | 28-10-10 |
Yan-Qin Zhao
CTO | Chief Tech/Sci/R&D Officer | - | 27-12-19 |
Steve Pi
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chih Hui Lin
CHM | Chairman | - | 28-10-10 |
Te Chien Chou
BRD | Director/Board Member | 66 | 02-04-14 |
Wei Hsiu Wu
CEO | Chief Executive Officer | - | 01-11-11 |
Hsiu Mei Lin
BRD | Director/Board Member | - | 11-06-15 |
Te Chuan Fan
BRD | Director/Board Member | 41 | 11-06-15 |
Fang Ping Chen
BRD | Director/Board Member | - | 23-05-17 |
Hui Lan Chiu
BRD | Director/Board Member | - | 22-09-21 |
Chi-Rui Li
BRD | Director/Board Member | - | 03-03-22 |
De-Ren Liu
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 137 409 000 | 69 661 500 ( 50,70 %) | 0 | 50,70 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,53% | 116 mln. | |
+14,99% | 78,65 mld. | |
+8,54% | 8,94 mld. | |
-12,05% | 5,16 mld. | |
+53,66% | 4,85 mld. | |
+11,63% | 4,19 mld. | |
-23,67% | 2,32 mld. | |
+12,07% | 2,29 mld. | |
-32,35% | 2,19 mld. | |
+21,04% | 2,19 mld. |
- Beurs
- Aandelen
- Koers 6461
- Onderneming Intech Biopharm Corporation